People using a common blood pressure treatment are being urged to check their pill packets following a packaging mix-up. Health officials have issued an alert about a specific batch of Ramipril after discovering that some boxes contain the wrong strength of medication.
The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that the recall is a precautionary measure to ensure patient safety. This move comes after a report revealed a pack of 5mg capsules was found inside a box clearly labelled as the 10mg version.
Pharmacists and doctors have been told to stop distributing the affected stock and begin contacting anyone who may have purchased it recently. If you have been prescribed this medication, you should examine your current supply to ensure the capsules match the dosage on the outer carton.
MORE HEALTH
The MHRA recall said: “Crescent Pharma Limited is recalling one batch of Ramipril 10mg capsules as a precautionary measure due to a potential manufacturing error, which may mean some cartons contain blister strips of a lower dose, specifically Ramipril 5mg. This follows a complaint from a patient where it was identified that, inside a sealed carton of Ramipril 10mg capsules (Batch No.: GR174091), one blister pack of Ramipril 5mg capsules (Batch No.: GR164094) was found.”
Health professionals are working to trace the medication distributed over the last year to minimise any risk to the public. The focus is on finding patients who received the supply recently, though much of the batch was released in 2025, reports Steven Smith on Chronicle Live.
Dr Alison Cave, MHRA chief safety officer, explained that both strengths of the capsule were used to treat high blood pressure, heart failure and kidney disease. She said “Any possible impact of a lower dose of Ramipril is expected to be gradual rather than immediate or life-threatening.Â
“If you have an impacted pack or previously received this batch and you believe you have taken any Ramipril 5mg capsules that were included in error and are currently experiencing any adverse effects, please seek medical advice. Please take the leaflet that came with your medicine and any remaining tablets with you to your pharmacy or GP practice. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme,” she said.
READ NEXT